Ocular Therapeutix Inc (NASDAQ:OCUL)
| 7.41 Delayed Data As of 3:59pm ET |  -0.20 / -2.63%Today’s Change | 2.57 Today|||52-Week Range 7.74 | +163.70% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 30.8M | 32.9M | 41.5M | 54.1M | |
| Short Term Investment Cash | -6.6M | 2.2M | 8.6M | 17.5M | ||
| Cash & Short Term Investments | 105.1M | 68.1M | 41.5M | 54.1M | ||
| Receivables | Receivables | 193.0K | 250.0K | 226.0K | 201.0K | |
| Inventories | Inventories | 134.0K | 113.0K | 122.0K | 217.0K | |
| Current Assets | Other Current Assets | 1.6M | 1.4M | 1.3M | 1.7M | |
| Current Assets | 107.0M | 69.9M | 43.2M | 56.2M | ||
| Total Assets | Property, Plant and Equipment - Gross | 6.0M | 7.1M | 15.8M | 17.9M | |
| Depreciation | -2.9M | -3.8M | -5.3M | -7.6M | ||
| Other Assets | 0.00 | 0.00 | 108.0K | 0.00 | ||
| Total Assets | 110.3M | 74.9M | 55.4M | 73.0M | ||
| Liabilities | Accounts Payable | 2.0M | 2.1M | 3.6M | 3.0M | |
| Short Term Debt | 0.00 | 1.5M | 5.5M | 0.00 | ||
| Accrued Expenses | 1.8M | 4.6M | 1.4M | 2.6M | ||
| Other Current Liabilities | 1.8M | 4.6M | 1.4M | 2.6M | ||
| Other Liabilities | 5.4M | 8.3M | 13.4M | 9.2M | ||
| Total Liabilities | Long Term Debt | 15.3M | 14.1M | 12.5M | 24.8M | |
| Other Liabilities | 68.0K | 537.0K | 3.4M | 3.2M | ||
| Total Liabilities | 20.7M | 22.9M | 29.3M | 37.2M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 89.6M | 52.0M | 26.1M | 35.9M | ||
| Total Shareholder Equity | 89.6M | 52.0M | 26.1M | 35.9M | ||
| Share Information | Common Shares Outstanding | 24.8M | 25.0M | 29.7M | 41.5M | |
| Addtl. Info. | No data currently available for this section. | |||||
